kneat.com (KSI) Stock Price, News & Analysis

Company Overview

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies have shown that Kneat Gx reduces man-hours associated with validation documentation by up to 50%, accelerates review and approval cycles by up to 50%, and consistently supports higher standards of regulatory compliance.

Key Stats

• Today's Range: C$4.70 to C$5.05
• 50-Day Range: C$3.30 to C$5.27
• 52-Week Range: C$3.23 to C$6.87
• Volume: 254,539 shs
• Average Volume: 177,524 shs
• Market Capitalization: C$480.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$6.25
• Consensus Rating: Buy

kneat.com Stock Analysis - MarketRank™

kneat.com scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Buy

Consensus Rating

kneat.com has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 1 strong buy rating, 3 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

kneat.com has a consensus price target of C$6.25, representing about 22.8% upside from its current price of C$5.09.

Amount of Analyst Coverage

kneat.com has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of kneat.com is -254.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of kneat.com is -254.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

kneat.com has a PEG Ratio of 597.67. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

kneat.com has a P/B Ratio of 7.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KSI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

kneat.com does not currently pay a dividend.

Dividend Growth

kneat.com does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for kneat.com this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, kneat.com insiders have not sold or bought any company stock.

Percentage Held by Insiders

25.96% of the stock of kneat.com is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

4.83% of the stock of kneat.com is held by institutions.

Company Calendar

• Last Earnings: 5/13/2026
• Today: 5/14/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: TSE:KSI
• CIK: N/A
• Web: www.kneat.com
• Phone: 353 6 120 3826
• Fax: N/A
• Employees: 293
• Year Founded: N/A

Price Target and Rating

• Average Price Target for kneat.com: C$6.25
• High Price Target: C$7.00
• Low Price Target: C$5.50
• Potential Upside/Downside: +25.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): C($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 597.67
• Net Income: -C$8.62 million
• Net Margins: -3.71%
• Pretax Margin: N/A
• Return on Equity: -3.55%
• Return on Assets: -9.84%

Debt

• Debt-to-Equity Ratio: 53.89
• Current Ratio: 1.82
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: C$63.26 million
• Price / Sales: 7.60
• Cash Flow: C$0.38 per share
• Price / Cash Flow: 13.18
• Book Value: C$0.68 per share
• Price / Book: 7.34

Miscellaneous

• Outstanding Shares: 96,132,000
• Free Float: N/A
• Market Cap: C$480.66 million
• Optionable: Not Optionable
• Beta: 0.86